Skip to content
Acting Auditions – Lifestyle
Author:
Soter Services North America LLC
Aprea Therapeutics Announces Expansion of Intellectual Property Portfolio for Precision Oncology Programs
August 28, 2026
Aprea Therapeutics Provides ACESOT-1051 Program Update for WEE1 Inhibitor APR-1051: Accelerating and Expanding Enrollment. Clinical Data Presentation Planned for Q4 2026
July 30, 2026
Soter Insure Secures Series B Funding Led by Galaxy to Scale Its Digital Asset Insurance Solutions
July 29, 2026
Aprea Therapeutics Reports First Quarter 2026 Financial Results and Provides a Corporate Update
May 13, 2026
Soter Insure Receives Full License Approval from the Dubai Financial Services Authority
May 5, 2026